耐药谱系中甲氧西林敏感性的重新出现
该研究比较了英国一个流行克隆谱系(CC30-t018)的231株金黄色葡萄球菌全基因组序列,发现甲氧西林耐药至少两次独立获得,其中一次约1995年因选择优势导致克隆扩张,但2008至2012年分离的9株菌在体内丢失了耐药性。作者认为这提示耐药存在显著适合度代价,且与2000年代中期英国MRSA医院防控措施引入后选择优势降低有关。
要点
- 同一流行谱系中甲氧西林耐药至少独立获得两次,一次约1995年伴随克隆扩张。
- 2008至2012年分离的9株菌在体内丢失了甲氧西林耐药性。
- 基因型与表型耐药不完全一致,耐药丢失有特定遗传机制。
核心结论
- 该流行谱系近期重新出现甲氧西林敏感性,提示耐药具有显著适合度代价。
- 2000年代中期英国MRSA医院防控措施引入后,耐药的选择优势可能降低。
研究设计与样本
- 比较英国单一流行谱系(CC30-t018)231株金黄色葡萄球菌分离株的全基因组序列。
主要发现
- 甲氧西林耐药在该谱系中至少两次独立获得,其中一次约1995年导致克隆扩张。
- 2008至2012年分离的9株菌在体内丢失了甲氧西林耐药性。
- 描述了耐药丢失涉及的遗传机制及基因型与表型耐药的不完全一致。
临床怎么用
- 解读MRSA监测时需注意同一谱系内耐药可丢失,基因型与表型耐药不完全一致。
- 医院MRSA防控措施可能通过降低耐药选择优势影响耐药演化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: MRSA is a leading cause of hospital-associated infection. Acquired resistance is encoded by the mecA gene or its homologue mecC , but little is known about the evolutionary dynamics involved in gain and loss of resistance. The objective of this study was to obtain an expanded understanding of Staphylococcus aureus methicillin resistance microevolution in vivo , by focusing on a single lineage. METHODS: We compared the whole-genome sequences of 231 isolates from a single epidemic lineage [clonal complex 30 (CC30) and spa -type t018] of S. aureus that caused an epidemic in the UK. RESULTS: We show that resistance to methicillin in this single lineage was gained on at least two separate occasions, one of which led to a clonal expansion around 1995 presumably caused by a selective advantage. Resistance was, however, subsequently lost in vivo by nine strains isolated between 2008 and 2012. We describe the genetic mechanisms involved in this loss of resistance and the imperfect relationship between genotypic and phenotypic resistance. CONCLUSIONS: The recent re-emergence of methicillin susceptibility in this epidemic lineage suggests a significant fitness cost of resistance and reduced selective advantage following the introduction in the mid-2000s of MRSA hospital control measures throughout the UK.
引用
- Ledda A, Price JR, Cole K, et al. Re-emergence of methicillin susceptibility in a resistant lineage of Staphylococcus aureus. J Antimicrob Chemother. 2017. PMID: 28108681. doi:10.1093/jac/dkw570
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。